Cocrystal Pharma (COCP) Total Non-Current Liabilities (2015 - 2026)
Cocrystal Pharma (COCP) reported Total Non-Current Liabilities of $989,000 for Q2 2026, down 26.2% from $1.34 million a year earlier and down 8.5% from the prior quarter.
Powered by 
Analysis
Cocrystal Pharma (COCP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Cocrystal Pharma posted Total Non-Current Liabilities of $1.17 million, down 22.2% from FY2024.
- Total Non-Current Liabilities has a five-year compound annual growth rate of 25.3% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $1.51 million in FY2024 (-6.7%), $1.61 million in FY2023, $57,000 in FY2022 (-80.9%) and $298,000 in FY2021 (-21.4%).
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q1 2023.
- Year over year, Total Non-Current Liabilities has now declined in each of the last three quarters, with an average decline of 16.9% over the last six quarters.
- Over the past five years, the year-over-year decline in Total Non-Current Liabilities ranged from 6.7% (Q4 2024) to 88.5% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Cocrystal Pharma | 13.24 Mn | -8.67 Mn | - | 989,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 989,000.00 |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.34 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 177,000.00 |
| Mar 31, 2022 | 234,000.00 |
| Dec 31, 2021 | 298,000.00 |
| Sep 30, 2021 | 358,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 336,000.00 |
| Dec 31, 2020 | 379,000.00 |
| Sep 30, 2020 | 425,000.00 |
API Access
Cocrystal Pharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=COCP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "COCP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=COCP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();